SLGC
Somalogic IncKey Statistics
About Somalogic Inc
SomaLogic Inc. (SLGC) is a leading biotechnology firm revolutionizing the field of precision medicine through its proprietary SomaScan® platform, which specializes in protein biomarker discovery and analysis. Leveraging an extensive library of proteins, the company is dedicated to developing advanced diagnostics and therapeutic applications targeting critical health issues such as cancer, cardiovascular diseases, and metabolic disorders. Positioned at the forefront of the biomarker industry, SomaLogic not only drives innovation in both research and clinical environments but also forges strategic partnerships to broaden its impact and accelerate the adoption of its transformative technologies. With a commitment to data-driven health solutions, SomaLogic is focused on enhancing patient outcomes and tailoring therapeutic strategies to individual needs, making it a key player in the future of personalized medicine.
Fundamentals
| Revenue (TTM) | $81.72M |
| Gross Profit (TTM) | $-11.27M |
| EBITDA | $-134.86M |
| Operating Margin | -108.50% |
| Return on Equity | -23.70% |
| Return on Assets | -14.20% |
| Revenue/Share (TTM) | $0.44 |
| Book Value | $2.63 |
| Price-to-Book | 0.80 |
| Price-to-Sales (TTM) | 4.85 |
| EV/Revenue | 0.137 |
| EV/EBITDA | 0.69 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -47.10% |
| Shares Outstanding | $188.68M |
| Float | $153.26M |
| % Insiders | 2.16% |
| % Institutions | 61.71% |
Historical Volatility
Volatility is currently expanding